Open AccessRisk Factors Influencing Antibody Responses to Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Antigens in Patients Under Antiretroviral Therapy
Author(s) -
Moraima Guadalupe,
Brad H. Pollock,
Steven D. Westbrook,
Spencer W. Redding,
Delia Bullock,
Gregory M. Anstead,
Brian K. Agan,
Vincent C. Marconi,
Sharon Barbieri,
Vidya Sankar,
Jennifer Rebeles,
Yvette Flahive,
John Schoolfield,
Linding Wang,
Xiufen Lei,
Dorothy Dow,
Chih Ko Yeh,
Howard Dang,
Anthony J. Infante,
ShouJiang Gao
Publication year - 2011
Publication title -
journal of acquired immune deficiency syndromes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.162
H-Index - 157
eISSN - 1944-7884
pISSN - 1525-4135
DOI - 10.1097/qai.0b013e3181fdc928
Subject(s) - lytic cycle , antibody , odds ratio , medicine , immunology , sarcoma , confidence interval , kaposi's sarcoma , antigen , virology , kaposi's sarcoma associated herpesvirus , viral disease , virus , herpesviridae , pathology , human herpesvirus
Kaposi's sarcoma-associated herpesvirus (KSHV) seropositivity and lytic antibody titer are predictors for Kaposi's sarcoma.